Hydreight Technologies Secures $4M in Financing, Fueling Growth and Expansion

Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing mobile clinical network and medical platform, has successfully raised over $4 million in a brokered private placement. The financing, led by Beacon Securities Limited, will support the company's long-term strategic objectives and enable it to execute several key initiatives.

1. Expanding the Doctor Network: Hydreight plans to use a significant portion of the funds to expand its nationwide network of doctors, meeting the growing demand across all 50 US states. This expansion will enable the company to provide more comprehensive healthcare services and increase its market reach.
2. Developing New Services and Offerings: The funds will be used to develop and launch new services and offerings, such as at-home testing services, which include genetic testing, food allergy testing, and diagnostic tests for specific conditions. This expansion will allow Hydreight to cater to a broader range of patient needs and attract more clients.
3. Investing in Technology and Infrastructure: The company will allocate a portion of the funds to invest in its proprietary, fully integrated platform. This investment will enhance the platform's capabilities, improve user experience, and ensure compliance with regulatory requirements across all 50 states.
4. Strengthening the Pharmacy Network: Hydreight will use the funds to further develop its 503B pharmacy network, which services all 50 states. This will enable the company to provide a more extensive range of pharmaceutical products and medications to its patients.
5. Supporting VSDHOne's Growth: A significant portion of the funds will be dedicated to supporting the growth and development of VSDHOne, Hydreight's innovative telemedicine and e-commerce platform. This investment will help VSDHOne expand its reach, onboard more licenses, and support its partners in launching and scaling their healthcare businesses.

The successful marketing period for Hydreight's brokered private placement indicates strong investor interest in the company's growth prospects, driven largely by the success of VSDHOne. The platform has contributed to Hydreight's revenue growth, with the company reporting a 54% year-over-year increase in revenue for Q3 2024 (Source: GlobeNewswire, Feb 18, 2025).



In conclusion, the completion of this financing round positions Hydreight Technologies to maintain and enhance its market position in the competitive mobile clinical network and healthcare technology sectors. With the additional capital, the company can execute its strategic initiatives, expand its services and platform, and continue to grow and innovate in the rapidly evolving healthcare landscape.